PLX vs. JIVE
PLX (Protalix BioTherapeutics, Inc.) is a stock, while JIVE (Jpmorgan International Value ETF) is Foreign Large Cap Equities fund actively managed by JPMorgan. Over the past year, PLX returned 22.50% vs 42.79% for JIVE. At a 0.27 correlation, their price movements are largely independent.
Performance
PLX vs. JIVE - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, PLX achieves a 8.89% return, which is significantly lower than JIVE's 15.75% return.
PLX
- 1D
- -1.51%
- 1M
- -7.98%
- YTD
- 8.89%
- 6M
- 13.95%
- 1Y
- 22.50%
- 3Y*
- -3.92%
- 5Y*
- -1.74%
- 10Y*
- -13.01%
JIVE
- 1D
- -1.02%
- 1M
- 4.12%
- YTD
- 15.75%
- 6M
- 20.07%
- 1Y
- 42.79%
- 3Y*
- —
- 5Y*
- —
- 10Y*
- —
PLX vs. JIVE - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | |
|---|---|---|---|---|
PLX Protalix BioTherapeutics, Inc. | 8.89% | -4.26% | 5.62% | 2.89% |
JIVE Jpmorgan International Value ETF | 15.75% | 49.80% | 11.22% | 5.38% |
Correlation
The correlation between PLX and JIVE is 0.35, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.35 |
Correlation (All Time) Calculated using the full available price history since Sep 15, 2023 | 0.27 |
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
PLX vs. JIVE — Risk / Return Rank
PLX
JIVE
PLX vs. JIVE - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Protalix BioTherapeutics, Inc. (PLX) and Jpmorgan International Value ETF (JIVE). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| PLX | JIVE | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -2.64 | ||
| Sortino ratioReturn per unit of downside risk | -2.99 | ||
| Omega ratioGain probability vs. loss probability | 1.12 | 1.53 | -0.40 |
| Calmar ratioReturn relative to maximum drawdown | 0.57 | 4.07 | -3.50 |
| Martin ratioReturn relative to average drawdown | 1.07 | 15.74 | -14.67 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading charts...
Sharpe Ratios by Period
| PLX | JIVE | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 0.34 | 2.98 | -2.64 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | -0.03 | — | — |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | -0.16 | — | — |
Sharpe Ratio (All Time)Calculated using the full available price history | -0.07 | 2.01 | -2.07 |
Drawdowns
PLX vs. JIVE - Drawdown Comparison
The maximum PLX drawdown since its inception was -99.91%, which is greater than JIVE's maximum drawdown of -13.79%. Use the drawdown chart below to compare losses from any high point for PLX and JIVE.
Loading charts...
Drawdown Indicators
| PLX | JIVE | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -99.91% | -13.79% | -86.12% |
Max Drawdown (1Y)Largest decline over 1 year | -39.68% | -10.57% | -29.11% |
Max Drawdown (3Y)Largest decline over 3 years | -62.96% | — | — |
Max Drawdown (5Y)Largest decline over 5 years | -73.21% | — | — |
Max Drawdown (10Y)Largest decline over 10 years | -94.37% | — | — |
Current DrawdownCurrent decline from peak | -99.78% | -1.02% | -98.76% |
Average DrawdownAverage peak-to-trough decline | -93.66% | -1.96% | -91.70% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 21.01% | 2.73% | +18.28% |
Volatility
PLX vs. JIVE - Volatility Comparison
Protalix BioTherapeutics, Inc. (PLX) has a higher volatility of 13.87% compared to Jpmorgan International Value ETF (JIVE) at 4.93%. This indicates that PLX's price experiences larger fluctuations and is considered to be riskier than JIVE based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| PLX | JIVE | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 13.87% | 4.93% | +8.94% |
Volatility (6M)Calculated over the trailing 6-month period | 44.36% | 11.99% | +32.37% |
Volatility (1Y)Calculated over the trailing 1-year period | 66.69% | 14.46% | +52.23% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 67.72% | 14.97% | +52.75% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 79.33% | 14.97% | +64.36% |
Dividends
PLX vs. JIVE - Dividend Comparison
PLX has not paid dividends to shareholders, while JIVE's dividend yield for the trailing twelve months is around 2.48%.
| Position | TTM | 2025 | 2024 | 2023 |
|---|---|---|---|---|
JIVE Jpmorgan International Value ETF | 2.48% | 2.88% | 2.48% | 0.74% |
PLX Protalix BioTherapeutics, Inc. | 0.00% | 0.00% | 0.00% | 0.00% |
Frequently Asked Questions
PLX and JIVE have a correlation of 0.35, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
PLX has higher volatility (13.87%) compared to JIVE (4.93%). In terms of maximum drawdown, PLX dropped -99.91% vs JIVE's -13.79%.
JIVE currently has the higher Sharpe Ratio (2.98 vs 0.34), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for PLX and JIVE
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer